From July 1, 2022 to September 30, 2022, the company has repurchased 16,117,100 shares, representing 0.86% for CNY 183.6 million. With this, the company has completed the repurchase of 36,138,098 shares, representing 1.94% for CNY 425.67 million under the buyback announced on April 26, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.17 CNY | -2.16% | +1.11% | +16.55% |
Apr. 29 | Jointown Pharma's Q1 Profit, Revenue Fall 4% | MT |
Apr. 29 | Jointown Pharmaceutical Group's 2023 Profit Jumps 4% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.55% | 4.41B | |
+16.70% | 70.09B | |
-1.72% | 24.01B | |
+8.01% | 8.32B | |
-18.28% | 8.23B | |
0.00% | 8.08B | |
+4.40% | 4.68B | |
-0.70% | 4.12B | |
-2.20% | 3.88B | |
+26.24% | 3.71B |
- Stock Market
- Equities
- 600998 Stock
- News Jointown Pharmaceutical Group Co., Ltd
- Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.